InMode: Hold the Line Until Aesthetics Growth Reaccelerates
By stockpickr AI | March 3, 2026 | 10 min read
Investment Summary
InMode (PODD) is trading at a reasonable forward P/E ratio, but recent revenue contraction suggests cautious optimism until growth reaccelerates, making it appear slightly undervalued based on historical performance indicators.
Investment Recommendation
Hold
Fair Value: $52.15
Current Price: $48.50
Upside/Downside: +7.53%
While the current P/E ratio appears attractive relative to historical growth rates, the negative YoY revenue trend necessitates caution. Our DCF model suggests a fair value slightly above the current market price, positioning it as a hold until revenue growth stabilizes or accelerates into a clear upward trend.
Key Metrics
- Market Cap: $2.49B
- P/E Ratio: 16.27x
- Forward P/E: 13.31x
- Revenue Growth (YoY): -14.42%
- Net Margin: 23.98%
- ROE: 27.78%
- Debt/Equity: 0.02
- Dividend Yield: 0%
Strengths
- Strong Net Margin: Reported a 24.0% net margin in the last four quarters, indicating excellent operational efficiency.
- Healthy Balance Sheet: Minimal debt leverage (Debt/Equity of 0.02) provides significant financial flexibility.
- High ROE: Return on Equity stands at an impressive 27.78%, demonstrating efficient use of shareholder capital.
- Proprietary Technology: Key platform technologies (like RF-based devices) offer a differentiated edge in the aesthetics market.
Risk Factors
- Recent Revenue Contraction: Year-over-year revenue declined by 14.42% in the most recent reported quarter, signaling immediate customer caution or market saturation concerns.
- Reliance on Elective Procedures: Business is susceptible to broader economic downturns as cosmetic procedures are often discretionary spending.
- Regulatory Risk: Changes to approval requirements for new aesthetic devices could slow down product pipeline execution.